Washburn Theodore James Jr. — SEC Form 4 filings
SEC reporting owner CIK 1874199. 11 Form 4 filings on record with FilingPulse; latest filed 2026-03-05.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-02-14 to 2026-03-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 16 legs across 11 filings — 26,006 shares, $893,000 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 24.
- Largest priced transaction: sale of 8,546 shares @ $36.87 ($315,091) in AGIOS PHARMACEUTICALS, INC., filed 2025-09-09.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | Principal Accounting Officer | 11 | — | 16 legs · 26,006 sh · $893,000 | 24 |
Form 4 filings — Washburn Theodore James Jr.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-03-05 | 4 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Sale (S): 5,272 @ $28.88 | EDGAR |
| 2026-03-03 | 4 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Option exercise (M): 2,350 @ $0 · Sale (S): 698 @ $28.96 · Option exercise (M): 2,450 @ $0 · Sale (S): 727 @ $28.96 · Option exercise (M): 2,695 @ $0 · Sale (S): 798 @ $28.96 · +4 more | EDGAR |
| 2025-09-09 | 4 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Sale (S): 8,546 @ $36.87 | EDGAR |
| 2025-03-04 | 4 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Option exercise (M): 777 @ $0 · Sale (S): 231 @ $35.54 · Option exercise (M): 2,350 @ $0 · Sale (S): 697 @ $35.54 · Option exercise (M): 2,450 @ $0 · Sale (S): 727 @ $35.54 · +5 more | EDGAR |
| 2025-02-05 | 4 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Option exercise (M): 6,896 @ $0 · Sale (S): 2,272 @ $34.39 · Option exercise (M): 6,896 (derivative) @ $0 | EDGAR |
| 2024-11-13 | 4 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Sale (S): 772 @ $56.09 | EDGAR |
| 2024-06-05 | 4 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Sale (S): 1,362 @ $44.39 | EDGAR |
| 2024-03-07 | 4 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Sale (S): 1,913 @ $31.75 | EDGAR |
| 2024-03-05 | 4 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Option exercise (M): 777 @ $0 · Sale (S): 295 @ $32.57 · Option exercise (M): 2,350 @ $0 · Sale (S): 919 @ $32.57 · Grant/award (A): 7,350 (derivative) @ $0 · Option exercise (M): 777 (derivative) @ $0 · +1 more | EDGAR |
| 2024-02-22 | 4 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Sale (S): 504 @ $26.63 | EDGAR |
| 2024-02-14 | 4 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Option exercise (M): 777 @ $0 · Sale (S): 273 @ $25.14 · Option exercise (M): 777 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1874199 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →